FRIDAY, Jan. 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a second Alzheimer’s drug, lecanemab, despite reports of rare brain bleeds linked to use of the drug in some patients. However, the FDA pointed to the drug’s benefits, as well. “Alzheimer’s disease immeasurably incapacitatesContinue Reading

THURSDAY, Jan. 5, 2023 (American Heart Association News) — Racial and ethnic diversity among medical workers is critical to Americans’ health, but more needs to be done to recruit, train and support those professionals, a new report says. The report, published Thursday in the American Heart Association journal Circulation: CardiovascularContinue Reading

THURSDAY, Jan. 5, 2023 (HealthDay News) — Lecanemab: It’s an experimental medication that’s been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It’s also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6. However, the drug hasContinue Reading

WEDNESDAY, Jan. 4, 2023 (American Heart Association News) — When Damar Hamlin’s heart stopped, millions held their breath. Monday night in Cincinnati, the 24-year-old football player for the Buffalo Bills had a cardiac arrest after making a tackle. In the packed stadium, thousands watched as medical workers performed CPR andContinue Reading

TUESDAY, Jan. 3, 2023 (HealthDay News) — Could hydration hold the key to longevity? Maybe, suggests new research that discovered older adults who are properly hydrated may be healthier and live longer than those who aren’t, having less incidence of conditions like heart and lung disease. “Staying well-hydrated may slowContinue Reading